In addition, aPD-1@PMPNs promoted the activation of DCs in both tumor-draining and non-tumor-draining lymph nodes, as demonstrated by the increased CD80+CD86+ double-positive population (Fig. 7E and Fig. S11). Here, CD86 is linked to neoplasm.